Related Experiment Video

Updated: Apr 21, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

10.8K

Suprafenacine, an indazole-hydrazide agent, targets cancer cells through microtubule destabilization

Bo-Hwa Choi1, Souvik Chattopadhaya1, Le Nguyen Thanh2

  • 1Division of Structural Biology and Biochemistry, School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.

Plos One
|October 30, 2014
PubMed

Insights

Researchers discovered Suprafenacine (SRF), a novel molecule targeting microtubules. SRF effectively kills cancer cells, including drug-resistant types, by inducing apoptosis and bypassing resistance mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Microtubules are a validated cancer therapy target.
  • Existing tubulin-binding agents (TBAs) face challenges with toxicity and drug resistance.
  • Novel TBAs are needed to overcome these limitations in cancer treatment.

Purpose of the Study:

  • To identify and characterize a new tubulin-destabilizing molecule for cancer therapy.
  • To evaluate the anti-cancer efficacy and mechanism of action of Suprafenacine (SRF).
  • To explore SRF's potential against drug-resistant cancer cells.

Main Methods:

  • In silico screening of chemical libraries to identify potential TBAs.
  • Biochemical assays to confirm microtubule binding and polymerization inhibition.
  • Cell-based assays to assess cell cycle arrest, apoptosis, and drug resistance.

Main Results:

  • Suprafenacine (SRF) binds to microtubules at the colchicine-binding site, inhibiting polymerization.
  • SRF induces G2/M cell cycle arrest and triggers apoptosis through a mitochondria-mediated pathway.
  • SRF selectively inhibits cancer cell proliferation and demonstrates efficacy against P-glycoprotein-mediated multidrug-resistant cells.

Conclusions:

  • Suprafenacine (SRF) is a novel, cell-permeable tubulin-destabilizing agent with significant anti-cancer potential.
  • SRF's ability to bypass P-glycoprotein makes it effective against resistant cancer cell lines.
  • SRF represents a promising scaffold for developing new chemotherapeutic agents.

More Related Videos

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

7.0K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

12.8K

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K
Microtubule Instability02:17

Microtubule Instability

5.1K
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.0K
Microtubule Formation01:23

Microtubule Formation

Microtubules are dynamic structures that undergo continuous assembly and disassembly. They originate from specialized multi-protein complexes known as microtubule organizing centers or MTOCs. Within the MTOC, the point of origin of the microtubule is known as the minus end, while the end radiating outward is the plus end. Microtubules serve two primary functions — the organization of spindle complexes to separate sister chromatids during mitotic or meiotic cell division and the formation...
6.2K